Prediction of MRI relaxometry in the presence of hepatic steatosis by Monte Carlo simulations
- PMID: 39394902
- DOI: 10.1002/nbm.5274
Prediction of MRI relaxometry in the presence of hepatic steatosis by Monte Carlo simulations
Abstract
To develop Monte Carlo simulations to predict the relationship of with liver fat content at 1.5 T and 3.0 T. For various fat fractions (FFs) from 1% to 25%, four types of virtual liver models were developed by incorporating the size and spatial distribution of fat droplets. Magnetic fields were then generated under different fat susceptibilities at 1.5 T and 3.0 T, and proton movement was simulated for phase accrual and MRI signal synthesis. The synthesized signal was fit to single-peak and multi-peak fat signal models for and proton density fat fraction (PDFF) predictions. In addition, the relationships between and PDFF predictions were compared with in vivo calibrations and Bland-Altman analysis was performed to quantitatively evaluate the effects of these components (type of virtual liver model, fat susceptibility, and fat signal model) on predictions. A virtual liver model with realistic morphology of fat droplets was demonstrated, and and PDFF values were predicted by Monte Carlo simulations at 1.5 T and 3.0 T. predictions were linearly correlated with PDFF, while the slope was unaffected by the type of virtual liver model and increased as fat susceptibility increased. Compared with in vivo calibrations, the multi-peak fat signal model showed superior performance to the single-peak fat signal model, which yielded an underestimation of liver fat. The -PDFF relationships by simulations with fat susceptibility of 0.6 ppm and the multi-peak fat signal model were ( , ) at 1.5 T and ( , ) at 3.0 T. Monte Carlo simulations provide a new means for -PDFF prediction, which is primarily determined by fat susceptibility, fat signal model, and magnetic field strength. Accurate -PDFF calibration has the potential to correct the effect of fat on quantification, and may be helpful for accurate measurements in liver iron overload.
Keywords:
© 2024 John Wiley & Sons Ltd.
Similar articles
-
Effect of particle size on liver MRI relaxometry: Monte Carlo simulation and phantom studies.Magn Reson Med. 2024 Oct;92(4):1743-1754. doi: 10.1002/mrm.30154. Epub 2024 May 9. Magn Reson Med. 2024. PMID: 38725136
-
Impact of particle size on and fat fraction estimation for accurate assessment of hepatic iron overload and steatosis using MRI.Magn Reson Med. 2025 May;93(5):2176-2185. doi: 10.1002/mrm.30419. Epub 2025 Jan 2. Magn Reson Med. 2025. PMID: 39748534 Free PMC article.
-
Hepatic steatosis modeling and MRI signal simulations for comparison of single- and dual-R2* models and estimation of fat fraction at 1.5T and 3T.Comput Biol Med. 2024 May;174:108448. doi: 10.1016/j.compbiomed.2024.108448. Epub 2024 Apr 10. Comput Biol Med. 2024. PMID: 38626508 Free PMC article.
-
Improved liver fat and quantification at 0.55 T using locally low-rank denoising.Magn Reson Med. 2025 Mar;93(3):1348-1364. doi: 10.1002/mrm.30324. Epub 2024 Oct 9. Magn Reson Med. 2025. PMID: 39385473 Free PMC article.
-
Comparative review of algorithms and methods for chemical-shift-encoded quantitative fat-water imaging.Magn Reson Med. 2024 Feb;91(2):741-759. doi: 10.1002/mrm.29860. Epub 2023 Oct 10. Magn Reson Med. 2024. PMID: 37814776 Review.
Cited by
-
A dedicated phantom for exploring the interplay of fat and paramagnetic substances in quantitative susceptibility mapping.MAGMA. 2025 Jun 2. doi: 10.1007/s10334-025-01261-3. Online ahead of print. MAGMA. 2025. PMID: 40455356
References
REFERENCES
-
- Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7(4):195‐203. doi:10.1038/nrgastro.2010.21
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease‐meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73‐84. doi:10.1002/hep.28431
-
- Neven B, Ivan L, Lea S‐D, Vedran T, Marko D. Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol. 2012;18(30):3945‐3954. doi:10.3748/wjg.v18.i30.3945
-
- Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128(7):1898‐1906. doi:10.1053/j.gastro.2005.03.084
-
- Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of liver fat content with CT and MRI: state of the art. Radiology. 2021;301(2):250‐262. doi:10.1148/radiol.2021204288
MeSH terms
Grants and funding
- 2024AH050724/Scientific Research Project of Universities in Anhui Province
- 2023AH050636/Scientific Research Project of Universities in Anhui Province
- 62001005/National Natural Science Foundation of China
- 62301501/National Natural Science Foundation of China
- 2008085QH425/Anhui Provincial Natural Science Foundation
- XJ201811/Grants for Scientific Research of BSKY from Anhui Medical University
- R01 DK083380/NH/NIH HHS/United States
- R01 DK088925/NH/NIH HHS/United States
- R01 DK100651/NH/NIH HHS/United States
- K24 DK102595/NH/NIH HHS/United States
- YQYB2024010/Cultivation Plan for Outstanding Youth Teachers of Anhui Province
- R01 DK083380/NH/NIH HHS/United States
- R01 DK088925/NH/NIH HHS/United States
- R01 DK100651/NH/NIH HHS/United States
- K24 DK102595/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical